Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RPG Life Sciences Limited
RPGLIFE | NSE
2,033.10
INR21.70
1.08%
RPGLIFE | NSE
Loading StockChartView...
About RPG Life Sciences Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
2,033.10
Open
2,015.00
High
2,080.00
Low
1,986.70
RPG Life Sciences Limited an integrated pharmaceutical company develops manufactures and markets branded formulations generic and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories including immunosuppressants anti-psychotic anti-anginal anthelmentics anti-convulsant anti-spasmodic etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies such as nephrology rheumatology oncology gastroenterology cardiovascular diabetology orthopedics neuropsychiatry respiratory nutritional general urology anti-diabetic anti-dengue vitamins and minerals gynecology and pediatrics etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
View LessRPGLIFE | NSE
Risk
42.6
Sharpe
-0.33
Luna's Score
55/100
Recommendation
Hold
Luna says (RPGLIFE | NSE)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
38.6%1 month
42.6%3 months
41.8%6 months
32.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
50.00
Fwd. PE
-
Price to book
12.34
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
31.53
Ent. to rev.
7.56
PEG
-
Other Fundamentals
EBITDA
1.33B
MarketCap
33.64B
MarketCap(USD)
351.58M
Div. yield
0.57
Op. margin
20.42
Erngs. growth
21.10
Rev. growth
11.90
Ret. on equity
25.69
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
229.00
Range1M
289.80
Range3M
489.50
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.20
Price X volume
36.31M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 31.53 | 24.85 | Expensive |
| Ent. to Revenue | 7.56 | 11.40 | Cheaper |
| PE Ratio | 50.00 | 51.36 | Par |
| Price to Book | 12.34 | 6.83 | Expensive |
| Dividend Yield | 0.57 | 0.52 | Par |
| Std. Deviation (3M) | 41.77 | 42.17 | Par |
| Debt to Equity | - | 0.35 | - |
| Debt to Assets | - | 0.17 | - |
| Market Cap | 33.64B | 290.82B | Emerging |
